- Diffuse Large B-Cell Lymphoma in the Era of Precision Oncology: How Imaging Is Helpful
-
Shah HJ, Keraliya A, Jagannathan JP, Tirumani S, Lele VR, DiPiro PJ
- KMID: 2468122
- Korean J Radiol.
- 2017 Feb;18(1):54-70.
- doi: 10.3348/kjr.2017.18.1.54
Diffuse large B cell lymphoma (DLBCL) is the most common histological subtype of Non-Hodgkin's lymphoma. As treatments continues to evolve, so do imaging strategies, and positron emission tomography (PET) has... -
- CITED
-
- Close
- SHARE
-
- Close
- Immune-Checkpoint Inhibitors in the Era of Precision Medicine: What Radiologists Should Know
-
Braschi-Amirfarzan M, Tirumani S, Hodi FS, Nishino M
- KMID: 2468121
- Korean J Radiol.
- 2017 Feb;18(1):42-53.
- doi: 10.3348/kjr.2017.18.1.42
Over the past five years immune-checkpoint inhibitors have dramatically changed the therapeutic landscape of advanced solid and hematologic malignancies. The currently approved immune-checkpoint inhibitors include antibodies to cytotoxic T-lymphocyte antigen-4,... -
- CITED
-
- Close
- SHARE
-
- Close
- Future directions in overactive bladder treatment: Personalized medicine can be applied?
-
Lee KS
- KMID: 2344108
- Korean J Urol.
- 2015 Oct;56(10):671-672.
- doi: 10.4111/kju.2015.56.10.671
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
